Context Therapeutics Inc. (CNTX) Corporate Subsidiaries
Context Therapeutics Inc. (CNTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CNTX
CIK: 1842952
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerSteven Schinella
Audit LocationParsippany, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001687078-26-000020 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0001140361-26-032506 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-053378 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001628280-26-053347 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-29 | 8-K | 0001628280-26-051399 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0001214659-26-009404 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002242 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045789 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045784 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045780 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045778 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045775 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045762 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-24 | 8-K | 0001628280-26-045744 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001628280-26-043042 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-14 | 8-K | 0001628280-26-035793 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002036 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001140361-26-021316 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0001214659-26-006201 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-002869 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-08 | — | SCHEDULE 13G/A Filing | 0001213900-26-053988 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001628280-26-031267 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-04-30 | 8-K | 0001628280-26-029323 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001628280-26-027962 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001628280-26-027942 | View SEC Doc Filr Page |